HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Encouraging results for Plenaxis in prostate cancer trial.

Authors
JournalExpert review of anticancer therapy (Expert Rev Anticancer Ther) Vol. 3 Issue 2 Pg. 132-3 (Apr 2003) ISSN: 1473-7140 [Print] England
PMID12722871 (Publication Type: News)
Chemical References
  • Antineoplastic Agents, Hormonal
  • Oligopeptides
  • Testosterone
  • Prostate-Specific Antigen
  • abarelix
Topics
  • Antineoplastic Agents, Hormonal (adverse effects, therapeutic use)
  • Electrocardiography
  • Humans
  • Male
  • Oligopeptides (adverse effects, therapeutic use)
  • Prostate-Specific Antigen (blood)
  • Prostatic Neoplasms (drug therapy)
  • Testosterone (blood)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: